- Home
- CRM vs SNY Comparison
CRM vs SNY Comparison
Compare CRM & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRM | SNY |
|---|---|---|
| Founded | 1999 | 1994 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.0B | 104.5B |
| IPO Year | 2003 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CRM | SNY |
|---|---|---|
| Price | $205.37 | $45.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 36 | 5 |
| Target Price | ★ $278.74 | $58.00 |
| AVG Volume (30 Days) | ★ 11.0M | 3.0M |
| Earning Date | 05-27-2026 | 04-23-2026 |
| Dividend Yield | 0.97% | ★ 3.47% |
| EPS Growth | ★ 22.64 | N/A |
| EPS | ★ 2.42 | N/A |
| Revenue | ★ $8,391,984,000.00 | N/A |
| Revenue This Year | $12.24 | $3.49 |
| Revenue Next Year | $9.47 | $6.10 |
| P/E Ratio | $86.39 | ★ $6.14 |
| Revenue Growth | ★ 25.87 | N/A |
| 52 Week Low | $146.32 | $40.89 |
| 52 Week High | $269.11 | $52.68 |
Technical Indicators
Market Signals| Indicator | CRM | SNY |
|---|---|---|
| Relative Strength Index (RSI) | 63.62 | 62.69 |
| Support Level | $168.94 | $43.28 |
| Resistance Level | $208.10 | $48.66 |
| Average True Range (ATR) | 6.48 | 0.52 |
| MACD | 0.79 | 0.23 |
| Stochastic Oscillator | 78.42 | 87.91 |
Price Performance
Historical ComparisonAbout CRM Salesforce Inc.
Salesforce provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.